Article thumbnail

The Blood-Brain Barrier and Microvascular Water Exchange in Alzheimer's Disease

By Valerie C. Anderson, David P. Lenar, Joseph F. Quinn and William D. Rooney

Abstract

Alzheimer's disease (AD) is the most common form of dementia in the elderly. Although traditionally considered a disease of neurofibrillary tangles and amyloid plaques, structural and functional changes in the microvessels may contribute directly to the pathogenesis of the disease. Since vascular dysfunction often precedes cognitive impairment, understanding the role of the blood-brain barrier (BBB) in AD may be key to rational treatment of the disease. We propose that water regulation, a critical function of the BBB, is disturbed in AD and results in abnormal permeability and rates of water exchange across the vessel walls. In this paper, we describe some of the pathological events that may disturb microvascular water exchange in AD and examine the potential of a relatively new imaging technique, dynamic contrast-enhanced MRI, to quantify water exchange on a cellular level and thus serve as a probe of BBB integrity in AD

Topics: Hypothesis
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3114411
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). A .B o z z a o ,R .F l o r i s ,M .E .B a v i e r a ,A .A p r u z z e s e ,a n dG . Simonetti, “Diffusion and perfusion MR imaging in cases of Alzheimer’s disease: correlations with cortical atrophy and lesion load,”
  2. (2004). A .S .L o s s i n s k ya n dR .R .S h i v e r s ,“ S t r u c t u r a lp a t h w a y sf o r macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions.
  3. a a d o u n ,M .J .T a i t ,A .R e z ae ta l . ,“ A Q P 4g e n ed e l e t i o n in mice does not alter blood-brain barrier integrity or brain morphology,”
  4. (1992). A morphometricstudy oftheblood-brainbarrier inAlzheimer’s disease,”
  5. (2010). A n d e r s o n ,D .P .L e n a r ,J .F .Q u i n n ,J .A .K a y e ,X .L i ,a n d
  6. (2006). a n g ,E .J .G o l o b ,a n dM .Y .S u ,“ V a s c u l a rv o l u m e and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls,”
  7. (1998). A population study on blood-brain barrier function in 85-year-olds: relation to
  8. (2004). a r i s ,N .P a t e l ,A .D e l l e d o n n e ,A .Q u a d r o s
  9. (2000). a r k a s ,G .I .D eJ o n g ,E .A p r
  10. (2010). Altered expression of claudin family proteins in Alzheimer’s disease and vasculardementia brains,”Journal of Cellular and
  11. (2002). Alzheimerdisease andcerebrovascular pathology: an update,” J o u r n a lo fN e u r a lT r a n s m i s s i o n ,
  12. (2006). Amyloid β-peptide alters tight junction protein distribution and expression in brain microvessel endothelial cells,”
  13. (2001). and K.Duff,“Permeabilityofproteinsattheblood-brainbarrierin the normal adult mouse and double transgenic mouse model of Alzheimer’s disease,”
  14. (2007). andN.Bogdanovic,“Occludinis overexpressed in Alzheimer’s disease and vascular dementia,”
  15. (2006). Angiogenic proteins are expressed by brain blood vessels in Alzheimer’s disease,”
  16. (2003). ank e e lo v ,P .K .C o y le
  17. (2007). Aquaporin-4, homeostasis, and neurologic disease,”
  18. (2006). Astrocyteendothelial interactions at the blood-brain barrier,”
  19. (2007). B o w m a n ,J .A .K a y e ,M .M o o r e ,D .W a i c h u n a s
  20. (2005). B r o o m ,D .C .A n t h o n y ,A .M .B l a m i r ee ta l . ,“ M R I reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MSlike lesions in rat brain,”
  21. (1992). Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer’s disease: an immunoelectron microscopic study,”
  22. (2009). Blood-brain barrier permeability in Alzheimer’s disease: a case-control MRI study,” Psychiatry Research,v o l .
  23. (1997). Brain microvascular changes in Alzheimer’s disease and other dementias,”
  24. (2006). Can dynamic susceptibility contrast magnetic resonance imaging replace single-photon emission computed tomography in the diagnosis of patients with Alzheimer’s disease? A pilot study,”
  25. (2009). Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances,”
  26. (2000). Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders,
  27. (2003). Cerebral blood volume measurements by T2 ∗-weighted MRI and contrast infusion,”
  28. (2001). Cerebral microvascular pathology in aging and Alzheimer’s disease,”
  29. (2003). Converging pathogenic mechanisms in vascular and neurodegenerative dementia,”
  30. (2000). Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmalCardiovascular
  31. (2001). Deuterium quenching of 1H2O relaxation in the living rat brain,”
  32. (2000). Endothelial vesicles in the blood-brain barrier: are they related to permeability?”
  33. (1999). Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo,”
  34. (1999). Estimating kinetic parameters from dynamic contrast-enhanced T- weighted MRI of a diffusable tracer: standardized quantities and symbols,”
  35. (2004). Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology,”
  36. (2005). Evidence for shutter-speed variationinCRbolus-trackingstudiesofhuman pathology,”
  37. (1998). G.J.Harris,R.F.Lewis,A.Satlinetal.,“Dynamicsusceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine,”
  38. (1996). G.J.Harris,R.F.Lewis,A.Satlinetal.,“Dynamicsusceptibility contrastMRIofregionalcerebral bloodvolumeinAlzheimer’s disease,”
  39. (2006). h i a p p e l l i ,B .B o r r o n i ,S .A r c h e t t ie ta l .
  40. (2008). h o u ,H .K o n g ,X .H u a ,M .X i a o ,J .D i n g ,a n dG .H u , “Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice,”
  41. (2005). i ,W .D .R o o n e y ,a n dC .S .S p r i n g e r ,“ Au n i fi e dm a g n e t i c resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents,”
  42. (2010). Iandiev et al., “Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress,”
  43. (2003). j i i e ,D .L .D i c k s t e i n ,D .A .C a r l o w ,a n dW .A .J e fferies, “Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model,”
  44. (2006). K j ø l b y ,L .Ø s t e r g a a r d ,a n dV .G .K i s e l e v ,“ T h e o r e t i c a l model of intravascular paramagnetic tracers effect on tissue relaxation,” Magnetic Resonance in Medicine,v ol.56,no .1,p p .
  45. (2005). Loss of perivascular aquaporin 4 may underlie deficient water and K homeostasis in the human epileptogenic hippocampus,”
  46. (2007). Low serum VEGF levels are associated with Alzheimer’s disease,”
  47. (1997). M a a s ,G .J .H a r r i s ,A .S a t l i n ,C .D .E n g l i s h ,R .F .L e w i s
  48. (1991). Measurement of the bloodbrain barrier permeability and leakage space using dynamic
  49. (2009). Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease,”
  50. Neurovascular mechanisms of Alzheimer’s neurodegeneration,”
  51. (2007). o c h i m s e n ,R .D .N e w b o u l d ,S .T .S k a r ee ta l . ,“ I d e n t i -fying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high-resolution multi-echo parallel EPI,”NMR in Biomedicine,
  52. (2006). ocsi,andJ.Stone,“Microvascularpathology intheaginghumanbrain:evidencethatsenileplaques aresites of microhaemorrhages,”Neurobiology of Aging,
  53. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study,”
  54. (2003). P r e s t o n ,P .V .S t e a r t ,A .W i l k i n s o n ,J .A .R .N i c o l l
  55. (2003). Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells,”
  56. (2004). Pathological aging of the brain: an overview,”
  57. (2009). Pathology and new players in the pathogenesis of brain edema,”
  58. (2000). Perfusion abnormalities in prodromal
  59. (2011). Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy,”
  60. (1990). Quantitation of bloodbrain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors,”
  61. (2003). Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer’s disease: a correlative study,”
  62. (1997). Quantitative magnetic resonance imaging of capillary water permeability and regional blood volume with an intravascular
  63. R o o n e y ,T .E .Y a n k e e l o v ,P .K .C o y l ee ta l . ,“ R e g i o n a l blood volumes and intravascular water lifetimes in human brain,”
  64. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide,”
  65. (2003). SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier,”
  66. (2008). T h a l
  67. (2003). T1: the longitudinal relaxation time,”
  68. (2006). The aquaporin water channels,”
  69. (2004). The bloodbrain barrier: an overview: structure, regulation, and clinical implications,”Neurobiology of Disease,vol.
  70. (2007). The integrity of the bloodbrain barrier in Alzheimer’s disease,”
  71. (2003). The molecular basis of water transport in the brain,”
  72. (2004). Towards a molecular understanding of water homeostasis in the brain,”
  73. (2004). u w e l t ,N .H .G r e i g ,C .R a ffel et al., “Mechanisms of disease: the blood-brain barrier,”
  74. (1996). Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer’s disease patients,”
  75. (2009). Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer’s disease,”
  76. (2003). Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline,”
  77. (2009). VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown,”
  78. (2009). VEGF-mediated disruption of endothelial CLN5 promotes blood-brain barrier breakdown,”
  79. (2008). Water movements in the brain: role of aquaporins,”Trends in
  80. (2005). White matter, brain edema, blood brain barrier,”
  81. (2007). Z.Zador,O.Bloch,X.Yao,andG.T.Manley,“Aquaporins:role in cerebral edema and brain water balance,”
  82. (1993). β-Amyloid(1-42) is a major component of cerebrovascular amyloid deposits: implicationsforthe pathologyofAlzheimerdisease,”